This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Boehringer Ingelheim Animal Health USA Inc., Sanofi Pasteur Sa. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 94 
1 out of 47 Years Active: 2023
Title: Lydie Remolue: Pioneering Innovations in Immunogenic Formulations
Introduction
Lydie Remolue is an innovative inventor based in Lyons, France. She has made significant contributions to the field of immunology and vaccine development. With her expertise, she has developed a patent that promises to enhance the effectiveness and safety of vaccines for various target animals.
Latest Patents
Lydie holds one patent titled “Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants.” This invention provides novel immunological and vaccine formulations that utilize a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants are designed to be combined with a wide variety of immunogens, resulting in safe and effective vaccines for a diverse range of target animals. Immunogens may include inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids, or combinations thereof. The target animals for these innovative vaccines can range from humans to various species including murine, canines, felines, equines, porcines, ovines, caprines, and bovines.
Career Highlights
Throughout her career, Lydie has gained valuable experience by working with leading companies in the pharmaceutical sector. She has been associated with Sanofi Pasteur SA and Boehringer Ingelheim Animal Health USA Inc., where she has applied her knowledge to advance health solutions.
Collaborations
Lydie has collaborated with esteemed colleagues such as Guillaume Rigaut and Alexis Guy André Lucien Parisot. These partnerships have contributed to the innovative developments in her research, further establishing her as a key figure in the biomedical field.
Conclusion
Lydie Remolue's work in immunogenic formulations showcases her commitment to advancing public health through innovative vaccine development. Her patent reflects her expertise and dedication to improving vaccine safety and efficacy across multiple animal species, making her a noteworthy inventor in the realm of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile